Cognition Therapeutics, Inc. · NASDAQ:CGTX
Cognition Therapeutics, Inc. shareholders
As of Jun 30, 2026, 63 institutions reported holding Cognition Therapeutics, Inc., 23.8% of its shares. Largest: BIOS Capital Management, LP, DAVENPORT & Co LLC and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Cognition Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| BIOS Capital Management, LP | 6M | 6.3% | no change | Aug 14, 2026 |
| DAVENPORT & Co LLC | 4.26M | 4.5% | +1.37M | Jul 13, 2026 |
| Vanguard | 3.98M | 4.2% | +482K | Aug 13, 2026 |
| BlackRock | 1.26M | 1.3% | +294K | Aug 7, 2026 |
| Chescapmanager LLC | 997K | 1.0% | no change | Aug 14, 2026 |
| Geode Capital | 910K | 0.96% | −10,202 | Aug 12, 2026 |
| Renaissance Technologies | 693K | 0.73% | −424K | Aug 13, 2026 |
| Hilton Capital Management, LLC | 549K | 0.58% | no change | Aug 4, 2026 |
| CM Management, LLC | 450K | 0.47% | +50,000 | Aug 13, 2026 |
| Dauntless Investment Group, LLC | 372K | 0.39% | −59,299 | Aug 13, 2026 |